FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Debbie Van Baarle

Research Profile

Anatomy

Disorders

Living Beings

Concepts & Ideas

Chemicals & Drugs

Physiology

Procedures

Co-author Network

Publications

TOP 3
L L Reubsaet; E A M Sanders; Debbie Van Baarle; Jaap Jan Boelens; A P J de Pagter; L Keukens; Nening M Nanlohy; Berent J Prakken; Isme De Kleer
Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease.
R Oostvogels; R M Spaapen; E Spierings; G D te Raa; Debbie Van Baarle; M van Elk; Arjan Buijs; B Giovannone; M Griffioen; Arnon P Kater; Henk M Lokhorst; Monique C Minnema; Tuna Mutis
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.
Dan Koning; Kristin Ladell; Katherine K Matthews; John J Miles; Nening M Nanlohy; David A Price; Ingrid M M Schellens; José A M Borghans; Ana I Costa; Ilka Hoof; Can Kesmir; Vanessa Venturi; Debbie Van Baarle
CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Debbie Van Baarle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: L L Reubsaet; E A M Sanders; Debbie Van Baarle; Jaap Jan Boelens; A P J de Pagter; L Keukens; Nening M Nanlohy; Berent J Prakken; Isme De Kleer
Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease.
Bone marrow transplantation 2013;48(4):502-7.
2013: R Oostvogels; R M Spaapen; E Spierings; G D te Raa; Debbie Van Baarle; M van Elk; Arjan Buijs; B Giovannone; M Griffioen; Arnon P Kater; Henk M Lokhorst; Monique C Minnema; Tuna Mutis
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.
Leukemia 2013;27(3):642-9.
2013: Dan Koning; Kristin Ladell; Katherine K Matthews; John J Miles; Nening M Nanlohy; David A Price; Ingrid M M Schellens; José A M Borghans; Ana I Costa; Ilka Hoof; Can Kesmir; Vanessa Venturi; Debbie Van Baarle
CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(3):931-9.
2013: Thijs Feuth; Justin H Fransen; Andy I M Hoepelman; Nening M Nanlohy; Peter D Siersema; Joop E Arends; Karel J van Erpecum; Debbie Van Baarle
Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection.
PloS one 2013;8(3):e59302.
2012: Thijs W H Flinsenberg; Mark Klein; Dan Koning; Debbie Van Baarle; Femke J Amelung; Jaap Jan Boelens; Ewoud B Compeer; Marianne Boes
Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells.
Blood 2012;120(26):5163-72.
2012: Desta Kassa; Tsehaynesh Messele; Tom H M Ottenhoff; Leonie Ran; Alemayehu Selase; Mekashaw Tebeje; Belete Tegbaru; Amelewerk Alemu; Kees L M C Franken; Annemieke H Friggen; Wudneh Geberemeskel; Krista E van Meijgaarden; Dawit Wolday; Debbie Van Baarle
Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.
Clinical and vaccine immunology : CVI 2012;19(12):1907-15.
2012: A P J de Pagter; Nening M Nanlohy; Elisabeth A M Sanders; J Scherrenburg; Rob Schuurman; kiki tesselaar; Jaap Jan Boelens; T Vroom-de Blank; Debbie Van Baarle
First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
Clinical immunology (Orlando, Fla.) 2012;144(3):179-89.
2012: Debbie Van Baarle
T-cells and cardiac complications in infectious mononucleosis.
Indian pediatrics 2012;49(3):189-90.
2012: Ilka Hoof; William H Hildebrand; Debbie Van Baarle; Can Kesmir
Proteome sampling by the HLA class I antigen processing pathway.
PLoS computational biology 2012;8(5):e1002517.
2011: Joop E Arends; Justin H Fransen; Andy I M Hoepelman; Debbie Van Baarle
Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.
International journal of antimicrobial agents 2011;38(6):538-9.
2011: Xiangyu Rao; Debbie Van Baarle; Ana Isabel C A Fontaine Costa; Ilka Hoof; Can Keşmir
HLA class I allele promiscuity revisited.
Immunogenetics 2011;63(11):691-701.
2011: Ingrid M M Schellens; Hanneke Schuitemaker; Debbie Van Baarle; Hanneke W M van Deutekom; Can Keşmir; Neeltje Kootstra; Frank Miedema; Marjon Navis; Ben Berkhout; Brigitte Boeser-Nunnink; José A M Borghans
Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
AIDS (London, England) 2011;25(14):1691-700.
2011: J E Arends; K R Hirsch; A I M Hoepelman; F J P Höppener; Nening M Nanlohy; J G Park; Debbie Van Baarle
Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.
Apoptosis : an international journal on programmed cell death 2011;16(9):959-66.
2011: Suzanne van Dorp; Scott J P Beijn; Roel de Weger; Saskia Ebeling; Frits Gmelig-Meyling; Edward F Knol; Henk Lokhorst; Ellen Meijer; Monique Minnema; Eefke Petersen; Floor Pietersma; Henrike Resemann; Liane te Boome; Debbie Van Baarle; Marijke van Dijk; Jürgen Kuball
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.
Haematologica 2011;96(9):1380-4.
2011: Janneke N Samsom; S Marieke van Ham; Rene E M Toes; Nico A Bos; Jan Damoiseaux; Debbie Van Baarle; Arjan A van de Loosdrecht; Martijn A Nolte
Guiding the action of the immune system: Interactions between the immune system and non-immune tissues: NVVI-Dutch society for Immunology Course, Lunteren, March 31st-April 1st, 2010.
Immunology letters 2011;138(1):1-3.
2011: Floor L Pietersma; Suzanne van Dorp; Monique C Minnema; Jürgen Kuball; Ellen Meijer; Rob Schuurman; Debbie Van Baarle
Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(7):e144-8.
2011: Charlotte H B S van den Berg; Robin van Houdt; Janke Schinkel; Debbie Van Baarle; Thijs J W van de Laar; Roel A Coutinho; Bart P X Grady; Richard Molenkamp; Maria Prins
Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.
PloS one 2011;6(11):e27555.
2011: Joop E Arends; Justin H Fransen; Tania Mudrikova; Ingrid M M Schellens; Sanne Nm Spijkers; Herman G Sprenger; Cari J Stek; Sander Van Assen; Debbie Van Baarle; Jori Symons; Andy Im Hoepelman
Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C.
Antiviral therapy 2011;16(7):979-88.
2011: Jolanda Scherrenburg; Ingrid M M Schellens; Debbie Van Baarle
Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
Antiviral therapy 2011;16(4):565-75.
2010: Ingrid M M Schellens; Katalin Pogany; Geertje H A Westerlaken; José A M Borghans; Frank Miedema; Irene G M van Valkengoed; Frank P Kroon; Joep M A Lange; Kees Brinkman; Jan M Prins; Debbie Van Baarle
Immunological analysis of treatment interruption after early highly active antiretroviral therapy.
Viral immunology 2010;23(6):609-18.
2010: Joop E Arends; Mark A A Claassen; Charlotte H S B van den Berg; Nening M Nanlohy; Karel J van Erpecum; Bert C Baak; Andy I M Hoepelman; Andre Boonstra; Debbie Van Baarle
T-cell responses at baseline and during therapy with peginterferon-alpha and ribavirin are not associated with outcome in chronic hepatitis C infected patients.
Antiviral research 2010;87(3):353-60.
2010: L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; Debbie Van Baarle; J M van Montfrans
T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.
Clinical and experimental immunology 2010;161(1):108-17.
2010: Evelien M Bunnik; Marit J van Gils; Marilie S D Lobbrecht; Linaida Pisas; Nening M Nanlohy; Debbie Van Baarle; Ad C van Nuenen; Ann J Hessell; Hanneke Schuitemaker
Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.
The Journal of general virology 2010;91(Pt 5):1354-64.
2010: F L Pietersma; S van Dorp; R Jacobi; L Ran; Nening M Nanlohy; Rob Schuurman; Monique C Minnema; Ellen Meijer; Debbie Van Baarle
High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(5):717-25.
2010: Ana I Fontaine Costa; Xiangyu Rao; Emmanuelle Lechenadec; Debbie Van Baarle; Can Keşmir
HLA-B molecules target more conserved regions of the HIV-1 proteome.
AIDS (London, England) 2010;24(2):211-5.
2010: P J de Pagter; Anne Virgili; Ellie Nacheva; Debbie Van Baarle; Rob Schuurman; Jaap J Boelens
Chromosomally integrated human herpesvirus 6: transmission via cord blood-derived unrelated hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):130-2.
2009: J E Arends; J Cohen Stuart; L C Baak; M E van der Ende; K J van Erpecum; C P M Simons; G J Boland; Debbie Van Baarle; A I M Hoepelman
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy.
Journal of viral hepatitis 2009;16(12):867-75.
2009: Suzanne van Dorp; Floor Pietersma; Matthias Wölfl; Leo F Verdonck; Eefke J Petersen; Henk M Lokhorst; Edwin Martens; Matthias Theobald; Debbie Van Baarle; Ellen Meijer; Jürgen Kuball
Rituximab treatment before reduced-intensity conditioning transplantation associates with a decreased incidence of extensive chronic GVHD.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):671-8.
2009: charlotte van den berg; T A Ruys; N M Nanlohy; Suzanne E Geerlings; J T M van der Meer; J-W Mulder; J A Lange; Debbie Van Baarle
Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
Journal of viral hepatitis 2009;16(4):239-48.
2009: Xiangyu Rao; Ana Isabel C A Fontaine Costa; Debbie Van Baarle; Can Kesmir
A comparative study of HLA binding affinity and ligand diversity: implications for generating immunodominant CD8+ T cell responses.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(3):1526-32.
2008: P J de Pagter; Rob Schuurman; Ellen Meijer; Debbie Van Baarle; Elisabeth A M Sanders; Anne P.J. Pagter
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2008;43(4):361-6.
2008: Debbie Van Baarle; Nening M Nanlohy; Sigrid Otto; Fiona J Plunkett; Jean M Fletcher; Arne N Akbar
Progressive telomere shortening of Epstein-Barr virus-specific memory T cells during HIV infection: contributor to exhaustion?
The Journal of infectious diseases 2008;198(9):1353-7.
2008: J Scherrenburg; E R W A N Piriou; Nening M Nanlohy; Debbie Van Baarle
Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.
Clinical and experimental immunology 2008;153(2):231-9.
2008: P J Anne de Pagter; Rob Schuurman; Henk Visscher; Machiel de Vos; Marc Bierings; Anton M van Loon; Cuno Uiterwaal; Debbie Van Baarle; Elisabeth A M Sanders; Anne P.J. Pagter
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):831-9.
2008: Floor Pietersma; Erwan Piriou; Debbie Van Baarle
Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.
Leukemia & lymphoma 2008;49(6):1028-41.
2008: T A Ruys; N M Nanlohy; charlotte van den berg; E Hassink; Marcel G H M Beld; T van de Laar; S Bruisten; F Wit; A Krol; Maria Prins; J Lange; Debbie Van Baarle
HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
Journal of viral hepatitis 2008;15(6):409-20.
2008: Marjon Navis; Ingrid M M Schellens; Peter van Swieten; José A M Borghans; Frank Miedema; Neeltje Kootstra; Debbie Van Baarle; Hanneke Schuitemaker
A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
The Journal of infectious diseases 2008;197(6):871-9.
2008: Ingrid M M Schellens; Can Keşmir; Frank Miedema; Debbie Van Baarle; José A M Borghans
An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: the contribution of prediction programs.
AIDS (London, England) 2008;22(1):33-7.
2008: Ingrid M M Schellens; José A M Borghans; Christine A Jansen; Iris M De Cuyper; Ronald B Geskus; Debbie Van Baarle; Frank Miedema
Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.
PloS one 2008;3(7):e2745.
2007: J Visser; Hans W Nijman; B-N Hoogenboom; P Jager; Debbie Van Baarle; Ed Schuuring; Wayel Habib Abdulahad; F Miedema; Ate G J van der Zee; Toos Daemen
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.
Clinical and experimental immunology 2007;150(2):199-209.
2007: Marjon Navis; Ingrid M M Schellens; Debbie Van Baarle; José A M Borghans; Peter van Swieten; Frank Miedema; Neeltje Kootstra; Hanneke Schuitemaker
Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):3133-43.
2007: Corine Bronke; Christine A Jansen; Geertje H A Westerlaken; Iris M De Cuyper; Frank Miedema; kiki tesselaar; Debbie Van Baarle
Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.
Clinical immunology (Orlando, Fla.) 2007;124(2):190-9.
2007: Aster Tsegaye; Leonie Ran; Dawit Wolday; Beyene Petros; Wendelien Dorigo; Erwan Piriou; Tsehaynesh Messele; Eduard Sanders; Tesfaye Tilahun; Deresse Eshetu; Hanneke Schuitemaker; Roel A Coutinho; Frank Miedema; José A M Borghans; Debbie Van Baarle
HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):389-400.
2007: Aster Tsegaye; Leonie Ran; Dawit Wolday; Beyene Petros; Nening M Nanlohy; Hailu Meles; Mulu Girma; Ermias Hailu; José A M Borghans; Frank Miedema; Debbie Van Baarle
Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.
AIDS (London, England) 2007;21(3):369-72.
2006: Vincent Bekker; Geertje H A Westerlaken; Henriëtte J Scherpbier; Sophie Alders; Hans L Zaaijer; Debbie Van Baarle; Taco W Kuijpers
Varicella vaccination in HIV-1-infected children after immune reconstitution.
AIDS (London, England) 2006;20(18):2321-9.
2006: Vincent Bekker; Henriëtte J Scherpbier; Marcel G H M Beld; Erwan Piriou; Alex Van Breda; Joep Lange; Frank van Leth; Suzanne Jurriaans; Sophie Alders; Pauline M E Wertheim-van Dillen; Debbie Van Baarle; Taco W Kuijpers
Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents.
The Journal of infectious diseases 2006;194(9):1323-30.
2006: Ester M M van Leeuwen; Jasper J Koning; Ester B M Remmerswaal; Debbie Van Baarle; René A W van Lier; Ineke J M ten Berge
Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(8):4998-5005.
2006: Belete Tegbaru; Dawit Wolday; Tsehaynesh Messele; Mengistu Legesse; Yared Mekonnen; Frank Miedema; Debbie Van Baarle
Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.
Clinical and vaccine immunology : CVI 2006;13(7):784-9.
2006: Nicola E Annels; Jayant S Kalpoe; R G M Bredius; Eric C J Claas; Aloys C M Kroes; Andrew D Hislop; Debbie Van Baarle; R Maarten Egeler; Maarten J D van Tol; Arjan C Lankester
Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(12):1743-8.
2006: Jeroen Visser; Debbie Van Baarle; Baukje Nynke Hoogeboom; Nathalie Reesink; Harry Klip; Ed Schuuring; Esther R Nijhuis; Michael Pawlita; Laura Bungener; Jacqueline de Vries-Idema; Hans W Nijman; Frank Miedema; Toos Daemen; Ate van der Zee
Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
International journal of cancer. Journal international du cancer 2006;118(10):2529-37.
2006: Erwan Piriou; Karel van Dort; Jan F L Weel; Frederike J Bemelman; Laila E Gamadia; Marinus H J van Oers; Debbie Van Baarle
Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
Clinical immunology (Orlando, Fla.) 2006;119(1):16-20.
2006: Christine A Jansen; Debbie Van Baarle; Frank Miedema
HIV-specific CD4+ T cells and viremia: who's in control?
Trends in immunology 2006;27(3):119-24.
2006: Christine A Jansen; Iris M De Cuyper; Berend Hooibrink; Akke K van der Bij; Debbie Van Baarle; Frank Miedema
Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study.
Blood 2006;107(4):1427-33.
2006: Mark J Geels; Christine A Jansen; Elly Baan; Iris M De Cuyper; Gijs J M van Schijndel; Hanneke Schuitemaker; Jaap Goudsmit; Georgios Pollakis; Frank Miedema; William A Paxton; Debbie Van Baarle
CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
Virology 2006;345(1):209-19.
2006: Christine A Jansen; Erwan Piriou; Iris M De Cuyper; Karel van Dort; Joep M A Lange; Frank Miedema; Debbie Van Baarle
Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Antiviral therapy 2006;11(1):105-16.
2005: Asrat Hailu; Debbie Van Baarle; Gerlinde J Knol; Nega Berhe; Frank Miedema; Piet A Kager
T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
Clinical immunology (Orlando, Fla.) 2005;117(2):182-91.
2005: Erwan Piriou; Karel van Dort; Nening M Nanlohy; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
Blood 2005;106(9):3166-74.
2005: Corine Bronke; Nanette M Palmer; Geertje H A Westerlaken; Mireille Toebes; Gijs M W van Schijndel; Veenu Purwaha; Krista E van Meijgaarden; Schumacher Ton; Debbie Van Baarle; kiki tesselaar; Annemieke Geluk
Direct ex vivo detection of HLA-DR3-restricted cytomegalovirus- and Mycobacterium tuberculosis-specific CD4+ T cells.
Human immunology 2005;66(9):950-61.
2005: Nico Kloosterboer; Paul H P Groeneveld; Christine A Jansen; Teun J K van der Vorst; Fransje Koning; Carel N Winkel; Ashley J Duits; Frank Miedema; Debbie Van Baarle; Ronald P van Rij; Kees Brinkman; Hanneke Schuitemaker
Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
Virology 2005;339(1):70-80.
2005: Erwan Piriou; Christine A Jansen; Karel van Dort; Iris M De Cuyper; Nening M Nanlohy; Joep M A Lange; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(3):2010-7.
2005: Christine A Jansen; Iris M De Cuyper; Radjin Steingrover; Suzanne Jurriaans; Sanjay U C Sankatsing; Jan M Prins; Joep M A Lange; Debbie Van Baarle; Frank Miedema
Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.
AIDS (London, England) 2005;19(11):1145-54.
2005: Dawit Wolday; Belete Tegbaru; Afework Kassu; Tsehaynesh Messele; Roel A Coutinho; Debbie Van Baarle; Frank Miedema
Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):265-71.
2005: Vincent Bekker; Corine Bronke; Henriëtte J Scherpbier; Jan F L Weel; Suzanne Jurriaans; Pauline M E Wertheim-van Dillen; Frank van Leth; Joep M A Lange; kiki tesselaar; Debbie Van Baarle; Taco W Kuijpers
Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.
AIDS (London, England) 2005;19(10):1025-34.
2005: Corine Bronke; Geertje H A Westerlaken; Frank Miedema; kiki tesselaar; Debbie Van Baarle
Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
Immunology letters 2005;97(2):215-24.
2005: Corine Bronke; Nanette M Palmer; Christine A Jansen; Geertje H A Westerlaken; Abeltje M Polstra; Peter Reiss; Margreet Bakker; Frank Miedema; kiki tesselaar; Debbie Van Baarle
Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
The Journal of infectious diseases 2005;191(6):873-80.
2005: Erwan Piriou; Karel van Dort; Nening M Nanlohy; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
European journal of immunology 2005;35(3):796-805.
2005: Debbie Van Baarle; Aster Tsegaye; Frank Miedema; Arne Akbar
Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system.
Immunology letters 2005;97(1):19-29.
2005: Christine A Jansen; Stefan Kostense; Kristin Vandenberghe; Nening M Nanlohy; Iris M De Cuyper; Erwan Piriou; Erik H Manting; Frank Miedema; Debbie Van Baarle
High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
European journal of immunology 2005;35(1):150-8.
2004: Christine A Jansen; Erwan Piriou; Corine Bronke; Jose Vingerhoed; Stefan Kostense; Debbie Van Baarle; Frank Miedema
Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors.
Clinical immunology (Orlando, Fla.) 2004;113(3):299-309.
2004: Erwan Piriou; Karel van Dort; Nening M Nanlohy; Frank Miedema; Marinus H J van Oers; Debbie Van Baarle
Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):6931-7.
2004: Fransje Koning; Christine A Jansen; Jos Dekker; Richard A Kaslow; Nicole Dukers; Debbie Van Baarle; Maria Prins; Hanneke Schuitemaker
Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour.
AIDS (London, England) 2004;18(8):1117-26.
2004: A C M Boon; Gerrie de Mutsert; Debbie Van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(4):2453-60.
2004: Mireille T M Vossen; Mi-Ran Gent; Jean-Claude Davin; Paul A Baars; Pauline M E Wertheim-van Dillen; Jan F L Weel; Marijke Th L Roos; Debbie Van Baarle; Jaap W Groothoff; René A W van Lier; Taco W Kuijpers
Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specific immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients.
Transplant international : official journal of the European Society for Organ Transplantation 2004;17(2):89-96.
2003: Aster Tsegaye; Dawit Wolday; Sigrid Otto; Beyene Petros; Tamrat Assefa; Tsegaye Alebachew; Ermias Hailu; Fekadu Adugna; Worku Measho; Wendelien Dorigo; Arnaud Fontanet; Debbie Van Baarle; Frank Miedema
Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.
Clinical immunology (Orlando, Fla.) 2003;109(3):338-46.
2003: Pauline Meij; Joost W J van Esser; Hubert G M Niesters; Debbie Van Baarle; Frank Miedema; Neil Blake; Alan B Rickinson; Ingrid Leiner; Eric G Pamer; Bob Lowenberg; Jan J Cornelissen; Jan W Gratama
Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease.
Blood 2003;101(11):4290-7.
2003: Afework Kassu; Aster Tsegaye; Dawit Wolday; Beyene Petros; mathias aklilu; EJ Sanders; Arnaud Fontanet; Debbie Van Baarle; Dörte Hamann; Tobias F Rinke De Wit
Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians.
Clinical and experimental immunology 2003;132(1):113-9.
2002: Debbie Van Baarle; Stefan Kostense; Marinus H J van Oers; Dörte Hamann; Frank Miedema
Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.
Trends in immunology 2002;23(12):586-91.
2002: Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; M Shirin Sabbaghian; Ronald L Rabin; Claire W Hallahan; Debbie Van Baarle; Stefan Kostense; Frank Miedema; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Mark Connors
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
Nature immunology 2002;3(11):1061-8.
2002: Debbie Van Baarle; Stefan Kostense; Egbert Hovenkamp; Graham S Ogg; Nening M Nanlohy; Margaret F C Callan; Nicole Dukers; Andrew J McMichael; Marinus H J van Oers; Frank Miedema
Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection.
AIDS (London, England) 2002;16(15):2001-11.
2002: Debbie Van Baarle; Katja C Wolthers; Egbert Hovenkamp; Hubert G M Niesters; Albert D M E Osterhaus; Frank Miedema; Marinus H J van Oers
Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
The Journal of infectious diseases 2002;186(3):405-9.
2002: Stefan Kostense; Sigrid A Otto; Gerlinde J Knol; Erik H Manting; Nening M Nanlohy; Christine Jansen; Joep M A Lange; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
European journal of immunology 2002;32(4):1080-9.
2002: Stefan Kostense; Kristin Vandenberghe; Jeanine Joling; Debbie Van Baarle; Nening M Nanlohy; Erik H Manting; Frank Miedema
Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS.
Blood 2002;99(7):2505-11.
2001: Debbie Van Baarle; Egbert Hovenkamp; Margaret F C Callan; Katja C Wolthers; Stefan Kostense; LC Tan; Hubert G M Niesters; Albert D M E Osterhaus; Andrew J McMichael; Marinus H J van Oers; Frank Miedema
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
Blood 2001;98(1):146-55.
2001: Stefan Kostense; Graham S Ogg; Erik H Manting; G Gillespie; Jeanine Joling; Kristin Vandenberghe; E Z Veenhof; Debbie Van Baarle; Suzanne Jurriaans; Michel Klein; Frank Miedema
High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
European journal of immunology 2001;31(3):677-86.
2000: Marijke Th L Roos; René A W van Lier; Dörte Hamann; Gerlinde J Knol; I Verhoofstad; Debbie Van Baarle; Frank Miedema; P T A Schellekens
Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
The Journal of infectious diseases 2000;182(2):451-8.
2000: Debbie Van Baarle; Egbert Hovenkamp; Nicole Dukers; Neil Renwick; Marie José Kersten; Jaap Goudsmit; Roel A Coutinho; Frank Miedema; Marinus H J van Oers
High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission.
The Journal of infectious diseases 2000;181(6):2045-9.
1999: Debbie Van Baarle; Egbert Hovenkamp; Marie José Kersten; Michel Klein; Frank Miedema; Marinus H J van Oers
Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
Blood 1999;93(11):3949-55.
1999: C Berger; Debbie Van Baarle; Marie José Kersten; Michel Klein; AS al-Homsi; B Dunn; Catherine McQuain; RH van Oers; H Knecht
Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.
The Journal of infectious diseases 1999;179(1):240-4.
1998: AS al-Homsi; C Berger; Debbie Van Baarle; Marie José Kersten; Michel Klein; Catherine McQuain; RH van Oers; H Knecht
Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection.
International journal of molecular medicine 1998;1(6):983-7.